Wim Lemahieu

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study

Robert De Smet, Bea Mellaerts, Hannelore Vandewinckele et al. · Journal of the American Medical Directors Association · 2020 · 198 citations · Full text

Retrospective Observational Study, Aging, Geriatrics +10

Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus

Wim Lemahieu, Monica Hermann, Anders Åsberg et al. · American Journal of Transplantation · 2005 · 147 citations

Molecular Pharmacology, Medicine, Cardiovascular Pharmacology +5

Cytochrome P450 3A4 and P-glycoprotein Activity and Assimilation of Tacrolimus in Transplant Patients with Persistent Diarrhea

Wim Lemahieu, Bart Maes, Kristin Verbeke et al. · American Journal of Transplantation · 2005 · 129 citations · Full text